Organometallics p. 6514 - 6517 (2012)
Update date:2022-08-16
Topics:
Manzini, Simone
Urbina Blanco, Cesar A.
Slawin, Alexandra M.Z.
Nolan, Steven P.
Novel ruthenium catalysts, [RuCl2(IPr*)(PPh 3)(3-phenylindenylidene)] (1) and [RuCl2(IPr*)(Py) (3-phenylindenylidene)] (2), bearing the very bulky ligand IPr* are reported. The complexes were tested in ring closing and cross-metathesis, and their activities were compared to that displayed by [RuCl2(IPr) (PPh3)(3-phenylindenylidene)] (3) and the new [RuCl 2(IPr)(Py)(3-phenylindenylidene)] (4), in order to assess how the steric hindrance of the N-heterocyclic carbene influences the catalytic activity of the resulting ruthenium complexes.
View MoreShanghai Yongyi Biotechnology Co., Ltd
Contact:+86-0512-69561955
Address:Suite 3005, City Gateway, No.398 North CaoXi Road, XuHui District, Shanghai 200030, China.
website:http://www.guarson.com
Contact:+86-523-88059600,+86-13805268803
Address:Room B1006,Yafang Building,Jiangyan Avenue,Jiangyan District, Taizhou City,Jiangsu,China
Jiangxi Lixin Pharmaceutical Co.,Ltd.
Contact:0798-8337222; 18979813215
Address:Jiangxi City, Jindezheng Province
CHANGZHOU HANGYU PHARMACEUTICAL TECHNOLOGY CO., LTD
website:http://www.czyys.com
Contact:0086-519-88802789
Address:No.300,Yanling Middle Road, Changzhou, Jiangsu, China
Oren Hydrocarbons (Qingdao) Co., Ltd.
Contact:+86-532-68607667-801
Address:Room 3 # 302, No.9 Qingyun Road, Qingdao, China
Doi:10.1002/ejic.202000258
(2020)Doi:10.1246/cl.1987.1945
(1987)Doi:10.1007/s11172-008-0020-0
(2008)Doi:10.1016/S0009-2614(00)00687-4
(2000)Doi:10.1016/j.bmc.2005.09.034
(2006)Doi:10.1016/j.jallcom.2015.11.188
(2016)